Bio-Rad Labs (BIO +12.3%) shares surge after the company says it has extended its marketing deal with research tool maker Luminex (LMNX +0.2%). Under the deal, BIO will hold the worldwide sales and distribution rights to LMNX's Magpix multiplexing instrument.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs